🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Squamous Cell Cancer of Head and Neck (SCCHN)

Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma NCT07125755Phase 37 sites📍 Guangzhou📍 Guangzhou📍 Guilin Sun Yat-sen University · Tests: Cisplatin Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome NCT06380686n/a2 sites📍 Essen📍 Hanover AIO-Studien-gGmbH · Tests: data collection A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites📍 Clovis📍 Los Angeles📍 Newport Beach Bristol-Myers Squibb · Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN NCT07264075Phase 31 site📍 Le Havre Groupe Oncologie Radiotherapie Tete et Cou · Tests: Ivonescimab 10 mg/kg, Ligufalimab, Pembrolizumab (KEYTRUDA ®) A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN NCT05751512Phase 31 site📍 Shanghai Lepu Biopharma Co., Ltd. · Tests: MRG003, Cetuximab injection, Methotrexate Injection Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy NCT07405645NA6 sites📍 Boston📍 New York📍 Portland University of Virginia · Tests: ExAblate Neuro A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC NCT07807163Phase 27 sites📍 Fort Myers📍 Orlando📍 St. Petersburg Bicara Therapeutics · Tests: Ficerafusp alfa, Pembrolizumab (KEYTRUDA®) Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck. NCT06856213Phase 217 sites📍 Santiago de Compostela📍 Badalona📍 Barcelona Grupo Español de Tratamiento de Tumores de Cabeza y Cuello · Tests: Cetuximab, Paclitaxel Intratumoral N17350 in Advanced Solid Tumors NCT07339176Phase 1, Phase 29 sites📍 Los Angeles📍 Los Angeles📍 San Diego Onchilles Pharma Inc · Tests: N17350 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery NCT02734537Phase 2679 sites📍 Birmingham📍 Anchorage📍 Anchorage ECOG-ACRIN Cancer Research Group · Tests: Cisplatin, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer NCT06736379Phase 11 site📍 Stanford VLP Therapeutics · Tests: VRP-encapsulated saRNA encoding IL-12 (1 x 10^9 viral particles per injection), Pembrolizumab (KEYTRUDA®), VRP-encapsul… A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors NCT07090499Phase 131 sites📍 Duarte📍 Irvine📍 Los Angeles Pfizer · Tests: PF-08046876, Pembrolizumab, Cisplatin, Carboplatin Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN NCT05260671Phase 22 sites📍 Changchun📍 Shanghai Eye & ENT Hospital of Fudan University · Tests: Penpulimab combined with cetuximab Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) NCT07460765Phase 11 site📍 Nashville Vanderbilt-Ingram Cancer Center · Tests: Nivo800, Nivolumab Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer NCT07348887NA1 site📍 Toronto University Health Network, Toronto · Tests: Daily adaptive radiation therapy, Image guided radiation therapy SMP-3124LP in Adults With Advanced Solid Tumors NCT06526819Phase 1, Phase 213 sites📍 Los Angeles📍 San Francisco📍 Denver Sumitomo Pharma America, Inc. · Tests: SMP3124LP Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck NCT06959108Phase 21 site📍 Villejuif Groupe Oncologie Radiotherapie Tete et Cou · Tests: Pucotenlimab, MRG003 A Beta-only IL-2 ImmunoTherapY Study NCT05086692Phase 1, Phase 228 sites📍 San Diego📍 San Francisco📍 Santa Monica Medicenna Therapeutics, Inc. · Tests: MDNA11, Pembrolizumab (KEYTRUDA®) Phase II Study of Ficerafusp Alfa in Combination With Nivolumab in Patients With Platinum-refractory Head and Neck Squamous Cell Carcinoma NCT07529873Phase 21 site📍 Villejuif Groupe Oncologie Radiotherapie Tete et Cou · Tests: Ficerafusp alfa, Nivolumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy